Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
QVAR for Reducing ED Return Visits in Asthma and COPD
NCT02499887Terminated
- Sponsor
- University at Buffalo
- Start
- Jan 2016
- Primary completion
- Sep 2016
- Countries
- 1
01
Overview
Randomised, open-label trial of beclomethasone in asthma and chronic obstructive pulmonary disease (COPD) (2 arms), sponsored by University at Buffalo. Primary endpoint: Percentage of Subjects With a Return Visit to the ED Within 30 Days of ED Discharge. Started Jan 2016; status: terminated.
02
Drugs
beclomethasone
03
Conditions
asthmachronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT02499887.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02499887.